Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2013-04-19

FDA Approved: SIMBRINZA — Original Application (Alcon Laboratories, Inc.)

View source ↗

Summary

The FDA approved SIMBRINZA (brinzolamide/brimonidine tartrate) through an original NDA by Alcon Laboratories, establishing it as a fixed-dose combination therap…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Simbrinza (brinzolamide/brimonidine)

Snippet

ORIG AP for SIMBRINZA (BRINZOLAMIDE/BRIMONIDINE TARTRATE)